The president of the Spanish Federation of Childhood Cancer Families asks for specific programs for survivors, home-based pediatric palliative care throughout Spain, and for families to participate in the design of health policies
The program gives greater weight to strategic medicines, antimicrobials, advanced therapies, biotechnological medicines, and those with a lower environmental impact
For Javier Padilla, the main challenge will be to provide the system with the necessary human and financial resources for the new model to work
The Chamber approves by assent - and on the occasion of World Allergy Day, which is celebrated on July 8 - an institutional declaration in support of the five points of the manifesto for safe schools for students at risk of anaphylaxis
Seven associations from the sector warn of the legal and economic insecurity of the new extended producer responsibility regime and ask the Government not to go beyond Brussels' demands
It will reform the special employment relationship of resident personnel in Health Sciences, a regulation that had remained practically unchanged since 2006
The Health Commission approves the reform that consolidates confidentiality in pharmaceutical funding agreements while the opposition denounces a lack of transparency and a legal change introduced through an amendment
A structural problem that happens in all autonomous communities
Opens an opportunity to improve the evaluation of treatments for rare diseases thanks to greater patient participation, better European coordination, and mechanisms to manage uncertainty
Incorporates tools such as conditional and provisional financing, risk-sharing agreements, and spending caps
Demands the Ministry, Health Departments and Strike Committee to reach agreements that help curb this crisis
Spain is a leader in research in this field, with 216 clinical trials that have recruited 4,088 patients in 2025
The standard can become a key tool for recovering the continent's innovative leadership
The 2026 European Drug Report warns of the increase in more potent substances, the rise of synthetic opioids, the expansion of cocaine use, and the growing use of ketamine among young people
Different institutions criticize the Draft Law approved by the Council of Ministers
The headquarters of the European Parliament in Madrid hosted the event on the occasion of World No Tobacco Day
Beatriz Perales (Sobi) will continue as president for the next two years
Demócrata interviews the general secretary of Fenin, the Spanish Federation of Health Technology Companies, who emphasizes, among other aspects, the need to boost national manufacturing to guarantee strategic autonomy and a greater commitment to value-based procurement.
The Community of Madrid will expand its neonatal screening program to 37 diseases before the end of the year.
Clinical trials for rare diseases increased by 4% in 2025 compared to the previous year, with a total of 216 studies
In Demócrata we talk, in the final stretch of the electoral campaign, with María Ángeles Prieto (Granada, 1961), secretary of Health of the PSOE of Andalusia, who assesses the actions of the Popular Party in this field, as well as her party's proposals to improve the health of Andalusians.
There is no specific treatment with antivirals or vaccine
In Demócrata we talk with Elena Nevado (Cáceres, 1969), Member of the European Parliament of the Popular Group. about the European Plan for Rare Diseases that the Public Health Committee (SANT) of the European Parliament is promoting.
The differentiated treatment of antimicrobials and the One Health approach, other of the main novelties
The initiative has been driven by its Secretary of Health, Robert F. Kennedy Jr. and the famous comedian and podcast host Joe Rogan
The Balearic Government announces its commitment to promote a regulation to guarantee the safety of minors with severe allergies in their educational environment
The popularly known as "heel prick test" is key for the early detection of rare diseases
The document pays special attention to prevention and to cognitive decline
For the moment, no supply problems are foreseen derived from the US NMF policy or the possible new tariffs
